BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33321617)

  • 21. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
    Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
    Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 27. Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity.
    Mohammadian S; Khazaei M; Maghami P; Avan A; Rezaei M
    Curr Cancer Drug Targets; 2023; 23(7):524-533. PubMed ID: 36809944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic Investigation into the Selective Anticancer Cytotoxicity and Immune System Response of Surface-Functionalized, Dichloroacetate-Loaded, UiO-66 Nanoparticles.
    Abánades Lázaro I; Haddad S; Rodrigo-Muñoz JM; Orellana-Tavra C; Del Pozo V; Fairen-Jimenez D; Forgan RS
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5255-5268. PubMed ID: 29356507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems.
    Kozlovskaya L; Stepensky D
    J Control Release; 2013 Oct; 171(1):17-23. PubMed ID: 23831053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
    Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
    Devulapally R; Sekar TV; Paulmurugan R
    Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient decoration of nanoparticles intended for intracellular drug targeting with targeting residues, as revealed by a new indirect analytical approach.
    Kaplun V; Stepensky D
    Mol Pharm; 2014 Aug; 11(8):2906-14. PubMed ID: 25040658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
    Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.